Navinci Featured in BioStock
Uppsala, Sweden – October 27, 2025 – Navinci has been featured in an article by BioStock highlighting the company’s unique technology and future ambitions.
The article includes an in-depth interview with CEO Jenny Sundqvist, who discusses Navinci’s innovative approach to mapping protein interactions directly in tissue and cell samples – revealing how proteins function together in their native context.
The article also highlights Navinci’s legacy, consistent double-digit growth, expanding product portfolio, and ongoing investment in multiplexing and spatial biology technologies.
Read the full article on BioStock here.
About Navinci
Navinci is a Swedish biotech company specializing in developing innovative solutions for studying in situ protein expression and interactions. With a focus and a strong legacy in developing in situ proximity ligation assay technology, Navinci has established itself as a center of excellence in the field and has a broad portfolio of products that help researchers study protein interactions in depth.
For any enquiries, please get in touch.
